Latest filing published 14 Apr 2011 for Aevi Genomic Medicine, LLC.
Insider track record
No signal scores available.
Joshua Kanter: trading record in brief
Joshua Kanter discloses dealings in Aevi Genomic Medicine, LLC to SEC (Form 4). The record holds 2 filings, all for trades on 13 April 2011.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 14 April 2011: a transaction, in Aevi Genomic Medicine, LLC. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Joshua Kanter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 23,908 sharesCommon StockSEC:0001144204-11-021924:0
- 14,978 sharesCommon StockSEC:0001144204-11-021924:1
2 of 2 declarations